← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Revenue increased 23.1% to $2.05B, while Net income decreased 77.5% to $84.7M.
The read at a glance✓ Audited against SEC data
- Earnings — FY2025 net income $84.7MOK
- Profitability — Net income $84.7MOK
- Balance-sheet lens — Credit, capital, funding and liquidityOK
- Accounting — No applicable forensic screenNote
- Insiders — 3 buys; 3 sells in 365 daysOK
- Capital — Comparable payout data unavailableNote
Business
Freedom Holding Corp.: As a result, we have realigned our reportable segments into the following four segments: Brokerage, Banking, Insurance, and Other.
Where the revenue comes from
Fiscal 2026, as Freedom Holding Corp. reports it. History and quarterly detail are in the app.
- Brokerage$831.5M
- Bank$689.2M
- Insurance$497.8M
- Other$172.8M
Leadership changes
From Freedom Holding Corp.'s own filings, the day they're filed.
- Kairat Kelimbetov · Directors · departureeff. 2026-07-08
- Valeriy Kim · Chief Financial Officer · appointmenteff. 2026-06-25
- Evgeny Ler · Chief Financial Officer · departureeff. 2026-06-25
Latest filings
- 10-Q · Quarterly report2026-08-10
- DEF 14A · Annual proxy (pay & governance)2026-07-29
- 8-K · Company announcement2026-07-10
- 8-K · Company announcement2026-07-10
- 8-K · Company announcement2026-06-29
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Freedom Holding Corp., every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.